Hefei Hengxin Life Science and Technology Co., Ltd.
Hefei Hengxin Life Science and Technology Co., Ltd. engages in the research and development, production, and sale of polylactic acid products in China, North America, Europe, Australia, and internationally. It offers paper and clear cups, cup lids, knives, forks, spoons, straws, stirring roads, foaming tableware, food packaging containers, packing bags, cup holders, and cup sleeves. The company w… Read more
Hefei Hengxin Life Science and Technology Co., Ltd. (301501) - Total Assets
Latest total assets as of June 2025: CN¥2.73 Billion CNY
Based on the latest financial reports, Hefei Hengxin Life Science and Technology Co., Ltd. (301501) holds total assets worth CN¥2.73 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hefei Hengxin Life Science and Technology Co., Ltd. - Total Assets Trend (2021–2024)
This chart illustrates how Hefei Hengxin Life Science and Technology Co., Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hefei Hengxin Life Science and Technology Co., Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Hefei Hengxin Life Science and Technology Co., Ltd.'s total assets of CN¥2.73 Billion consist of 36.1% current assets and 63.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 14.9% |
| Accounts Receivable | CN¥172.83 Million | 8.7% |
| Inventory | CN¥202.51 Million | 10.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥63.36 Million | 3.2% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Hefei Hengxin Life Science and Technology Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hefei Hengxin Life Science and Technology Co., Ltd.'s current assets represent 36.1% of total assets in 2024, a decrease from 49.8% in 2021.
- Cash Position: Cash and equivalents constituted 14.9% of total assets in 2024, down from 18.2% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 4.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 10.2% of total assets.
Hefei Hengxin Life Science and Technology Co., Ltd. Competitors by Total Assets
Key competitors of Hefei Hengxin Life Science and Technology Co., Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SAMRYOONG Co.Ltd
KQ:014970
|
Korea | ₩96.42 Billion |
|
Zhuhai Zhongfu Enterprise Co Ltd
SHE:000659
|
China | CN¥1.97 Billion |
|
Shin Hwa Silup
KO:001770
|
Korea | ₩84.01 Billion |
|
Huangshan Novel Co Ltd
SHE:002014
|
China | CN¥4.17 Billion |
|
Shenzhen Jinjia Color Printing Group Co Ltd
SHE:002191
|
China | CN¥8.43 Billion |
|
Export Packing
KO:002200
|
Korea | ₩347.30 Billion |
|
Xiamen Hexing Packaging Printing Co Ltd
SHE:002228
|
China | CN¥7.52 Billion |
|
Shenzhen Beauty Star Co Ltd
SHE:002243
|
China | CN¥16.63 Billion |
Hefei Hengxin Life Science and Technology Co., Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Hefei Hengxin Life Science and Technology Co., Ltd. generates 0.80x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Hefei Hengxin Life Science and Technology Co., Ltd. generates $ 11.08 in net profit.
Hefei Hengxin Life Science and Technology Co., Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.50 | 1.19 | 1.19 |
| Quick Ratio | 2.09 | 0.83 | 0.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥815.69 Million | CN¥ 106.54 Million | CN¥ 106.54 Million |
Hefei Hengxin Life Science and Technology Co., Ltd. - Advanced Valuation Insights
This section examines the relationship between Hefei Hengxin Life Science and Technology Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.13 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | 26.2% |
| Total Assets | CN¥1.98 Billion |
| Market Capitalization | $222.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hefei Hengxin Life Science and Technology Co., Ltd.'s assets below their book value (0.11 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Hefei Hengxin Life Science and Technology Co., Ltd.'s assets grew by 26.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Hefei Hengxin Life Science and Technology Co., Ltd. (2021–2024)
The table below shows the annual total assets of Hefei Hengxin Life Science and Technology Co., Ltd. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.98 Billion | +26.21% |
| 2023-12-31 | CN¥1.57 Billion | +29.60% |
| 2022-12-31 | CN¥1.21 Billion | +66.68% |
| 2021-12-31 | CN¥727.91 Million | -- |